Heart rate variability in type 2 diabetes mellitus

Critical Reviews in Biomedical Engineering

Volumn 41, Issue 2, 2013, Pages 137-147

  Stuckey, Melanie I ^a,b   Petrella, Robert J ^a,b,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c WESTERN UNIVERSITY   (Canada)

Author keywords

Autonomic nervous system; Exercise training; Heart rate variability; Type 2 diabetes

Indexed keywords

AUTONOMIC MODULATION; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX SENSITIVITIES; EXERCISE TRAINING; HEART RATE VARIABILITY; TIME AND FREQUENCY DOMAINS; TYPE 2 DIABETES MELLITUS; TYPE-2 DIABETES;

FREQUENCY DOMAIN ANALYSIS;

HEART;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS; EXERCISE; HEART RATE VARIABILITY; HUMAN; KINESIOTHERAPY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESSORECEPTOR REFLEX; PREVALENCE; PRIORITY JOURNAL;

AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 2; HEART RATE; HUMANS;

EID: 84890873913     PISSN: 0278940X     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevBiomedEng.2013008103     Document Type: Article

References (66)

1. Mendis S, Puska P, Norrving B, editors. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva, Switzerland: World Health Organization; 2011.
2. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta (GA): US Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
3. Kudat H, Akkaya V, Sozen AB, Salman S, Demirel S, Ozcan M, Atilgan D, Yilmaz MT, Guven O. Heart rate variability in diabetes patients. J Int Med Res. 2006;34:291-6.
4. Bigger JT Jr, Fleiss JL, Rolnitzky LM, Steinman RC, Schneider WJ. Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol. 1991;18:1643-9.
5. Kuusela T. Methodological aspects of baroreflex sensitivity analysis. In: Kamath MV, Watanabe M, and Upton ARM, editors. Heart Rate Variability Signal Analysis: Clinical Applications. Boca Raton (FL): CRC Press Inc; 2012, p. 43-58.
6. Kamath MV, Watanabe MA, Upton ARM. Heart rate variability: A historical perspective. In: In: Kamath MV, Watanabe M, and Upton ARM, editors. Heart Rate Variability Signal Analysis: Clinical Applications. Boca Raton (FL): CRC Press Inc; 2012, p. 1-8.
7. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93:1043-65.
8. Huikuri HV, Makikallio T, Airaksinen KE, Mitrani R, Castellanos A, Myerburg RJ. Measurement of heart rate variability: a clinical tool or a research toy? J Am Coll Cardiol. 1999;34:1878-83.
9. Raeder EA, Stys A, Cohen RJ. Effect of low-dose scopolamine on autonomic control of the heart. Ann Noninvasive Electrocardiol. 1997;2:236-41.
10. Serrador JM, Finlayson HC, Hughson RL. Physical activity is a major contributor to the ultra low frequency components of heart rate variability. Heart. 1999;82:e9.
11. Bernardi L, Valle F, Coco M, Calciati A, Sleight P. Physical activity influences heart rate variability and very-lowfrequency components in Holter electrocardiograms. Cardiovasc Res. 1996;32:234-7.
12. Taylor JA, Carr DL, Myers CW, Eckberg DL. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation. 1998;98:547-55.
13. Pagani M, Montano N, Porta A, Malliani A, Abboud FM, Birkett C, Somers VK. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation. 1997;95:1441-8.
14. Goldstein DS, Bentho O, Park MY, Sharabi Y. Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol. 2011;96:1255-61.
15. Rahman F, Pechnik S, Gross D, Sewell L, Goldstein DS. Low frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Clin Auton Res. 2011;21:133-41.
16. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985;248:H151-3.
17. Hayano J, Sakakibara Y, Yamada A, Yamada M, Mukai S, Fujinami T, Yokoyama K, Watanabe Y, Takata K. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol. 1991;67:199-204.
18. Penttilä J, Helminen A, Jartti T, Kuusela T, Huikuri HV, Tulppo MP, Coffeng R, Scheinin H. Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: Effects of various respiratory patterns. Clin Physiol. 2001;21:365-76.
19. Penttilä J, Helminen A, Luomala K, Scheinin H. Pharmacokinetic-pharmacodynamic model for the anticholinergic effect of glycopyrrolate. Eur J Clin Pharmacol. 2001;57:153-8.
20. Challapalli S, Kadish AH, Horvath G, Goldberger JJ. Differential effects of parasympathetic blockade and parasympathetic withdrawal on heart rate variability. J Cardiovasc Electrophysiol. 1999;10:1192-9.
21. Kleiger RE, Miller JP, Bigger JT Jr. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-62.
22. Masaoka S, Lev-Ran A, Hill LR, Vakil G, Hon EH. Heart rate variability in diabetes: relationship to age and duration of the disease. Diabetes Care. 1985;8:64-8.
23. Liao D, Carnethon M, Evans GW, Cascio WE, Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes. 2002;51:3524-31.
24. Gerritsen J, Dekker JM, Tenvoorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: The HOORN study. Diabetes Care. 2001;24:1793-8.
25. May O, Arildsen H. Long-term predictive power of heart rate variability on all-cause mortality in the diabetic population. Acta Diabetol. 2011;48:55-9.
26. Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens. 2001;14:304S-9S.
27. De Couck M, Mravec B, Gidron Y. You may need the vagus nerve to understand pathophysiology and to treat diseases. Clin Sci. 2012;122:323-8.
28. Vinik AI. The conductor of the autonomic orchestra. Front Endocrinol (Lausanne). 2012;3:71.
29. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.
30. Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPher son R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E; Cardiometabolic Risk Working Group: Executive Committee. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol. 2011;27:e1-33.
31. Assoumou HGN, Pichot V, Barthelemy JC, Dauphinot V, Celle S, Gosse P, Kossovsky M, Gaspoz JM, Roche F. Metabolic syndrome and short-term and long-term heart rate variability in elderly free of clinical cardiovascular disease: The PROOF study. Rejuvenation Res. 2010;13:653-63.
32. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, Shipley MJ, Kumari M, Andrew R, Seckl JR, Papadopoulos A, Checkley S, Rumley A, Lowe GD, Stansfeld SA, Marmot MG. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: Nested case-control study. Circulation. 2002;106:2659-65.
33. Chang C, Yang Y, Lu F, Lin T, Chen J, Yeh T, Wu CH, Wu JS. Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. Am J Med. 2010;123:432-8.
34. Chang Y, Lin J, Chen W, Yen C, Loh C, Fang W, Wu LW. Metabolic syndrome and short-term heart rate variability in adults with intellectual disabilities. Res Dev Disabil. 2012;33:1701-7.
35. Gehi AK, Lampert R, Veledar E, Lee F, Goldberg J, Jones L, Murrah N, Ashraf A, Vaccarino V. A twin study of metabolic syndrome and autonomic tone. J Cardiovasc Electrophysiol. 2009;20:422-8.
36. Koskinen T, Kähönen M, Jula A, Mattsson N, Laitinen T, Keltikangas-Järvinen L, Viikari J, Välimäki I, Rönnemaa T, Raitakari OT. Metabolic syndrome and short-term heart rate variability in young adults: The Cardiovascular Risk in Young Finns Study. Diabetic Med. 2009;26:354-61.
37. Min K, Min J, Paek D, Cho S. The impact of the components of metabolic syndrome on heart rate variability: Using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol. 2008;31:584-91.
38. Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, Heiss G. Diabetes, glucose, insulin, and heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2005;28:668-74.
39. Stein PK, Barzilay JI, Domitrovich PP, Chaves PM, Gottdiener JS, Heckbert SR, Kronmal RA. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: The Cardiovascular Health Study. Diabetic Med. 2007;24:855-63.
40. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study, 1987-1998. Circulation. 2003;107:2190-5.
41. Colberg SR, Albright AL, Blissmer BJ, Braun B, Chasan-Taber L, Fernhall B, Regensteiner JG, Rubin RR, Sigal RJ. Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc. 2010;42:2282-303.
42. Chudyk A, Petrella RJ. Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. Diabetes Care. 2011;34:1228-37.
43. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hamäläinen H, Ianne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
44. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673-9.
45. Lindstrom J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinanen-Kiukaanniemi S, Uusitupa M, Tuomilehto J. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2013;56:284-93.
46. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
47. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677-86.
48. Carnethon MR, Prineas RJ, Temprosa M, Zhang ZM, Uwaifo G, Molitch ME. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care. 2006;29:914-9.
49. Pagkalos M, Koutlianos N, Kouidi E, Pagkalos E, Mandroukas K, Deligiannis A. Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy. Br J Sports Med. 2008;42:47-54.
50. Loimaala A, Huikuri HV, Kööbi T, Rinne M, Nenonen A, Vuori I. Exercise training improves baroreflex sensitivity in type 2 diabetes. Diabetes. 2003;52:1837-42.
51. Figueroa A, Baynard T, Fernhall B, Carhart R, Kanaley JA. Endurance training improves post-exercise cardiac autonomic modulation in obese women with and without type 2 diabetes. Eur J Appl Physiol. 2007;100:437-44.
52. Zoppini G, Cacciatori V, Gemma ML, Moghetti P, Targher G, Zamboni C, Thomaseth K, Bellavere F, Muggeo M. Effect of moderate aerobic exercise on sympatho-vagal bal ance in type 2 diabetic patients. Diabet Med. 2007;24:370-6.
53. Lee K, Picard G, Beske SD, Hwang G, Taylor JA. Effects of fitness and age on the response to vagotonic atropine. Auton Neurosci. 2008;139:60-7.
54. Earnest CP, Blair SN, Church TS. Heart rate variability and exercise in aging women. J Womens Health (Larchmt). 2012;21:334-9.
55. Howorka K, Pumprla J, Haber P, Koller-Strametz J, Mondrzyk J, Schabmann A. Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res. 1997;34:206-14.
56. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387-97.
57. Neves VR, Kiviniemi AM, Hautala AJ, Karjalainen J, Piira OP, Catai AM, Mäkikallio TH, Huikuri HV, Tulppo MP. Heart rate dynamics after exercise in cardiac patients with and without type 2 diabetes. Front Physiol. 2011;2:57.
58. Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW, Cai J, Sharrett AR. Multiple metabolic syndrome is associated with lower heart rate variability: The Atherosclerosis Risk in Communities Study. Diabetes Care. 1998;21:2116-22.
59. Pagani M, Somers V, Furlan R, Dell'Orto S, Conway J, Baselli G, Cerutti S, Sleight P, Malliani A. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension. 1988;12:600-10.
60. Hautala AJ, Mäkikallio TH, Kiviniemi A, Laukkanen RT, Nissilä S, Huikuri HV, Tulppo MP. Heart rate dynamics after controlled training followed by a home-based exercise program. Eur J Appl Physiol. 2004;92:289-97.
61. Tulppo MP, Hautala AJ, Mäkikallio TH, Laukkanen RT, Nissilä S, Hughson RL, Huikuri HV. Effects of aerobic training on heart rate dynamics in sedentary subjects. J Appl Physiol. 2003;95:364-72.
62. Seals DR, Chase PB. Influence of physical training on heart rate variability and baroreflex circulatory control. J Appl Physiol. 1989;66:1886-95.
63. Jurca R, Church TS, Morss GM, Jordan AN, Earnest CP. Eight weeks of moderate-intensity exercise training increases heart rate variability in sedentary postmenopausal women. Am Heart J. 2004;147:G1-8.
64. Perini R, Fisher N, Veicsteinas A, Pendergast DR. Aerobic training and cardiovascular responses at rest and during exercise in older men and women. Med Sci Sports Exerc. 2002;34:700-8.
65. Martinmäki K, Häkkinen K, Mikkola J, Rusko H. Effect of low-dose endurance training on heart rate variability at rest and during an incremental maximal exercise test. Eur J Appl Physiol. 2008;104:541-8.
66. Cornelissen VA, Verheyden B, Aubert AE, Fagard RH. Effects of aerobic training intensity on resting, exercise and post-exercise blood pressure, heart rate and heart-rate variability. J Hum Hypertens. 2010;24:175-82.